Our mission is to make cancer care better for patients, clinicians, and communities. We work at the nexus of research and practice to create, test, and scale solutions to improve health, health care, and health equity for patients with cancer; enhance the patient and clinician experience; and increase care efficiency and value.
Our Initiatives
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Learn more
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Learn more
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Learn more
We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing healthcare.
Learn More
We integrate augmented and artificial intelligence into our solutions to predict health outcomes, support decision making, challenge bias, and enhance health equity.
Augmented & Artificial Intelligence
09.21.2023
PC3I Faculty Roger Kim, MD, MSCE has been awarded a K08 Mentored Clinical Scientist Career Development Award from the National Cancer Institute, which provides support and mentorship to clinician scientists for research and career development activities.
09.11.2023
PC3I is pleased to share our 2022-2023 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.
08.30.2023
A study led by PC3I Faculty Meredith Doherty, PhD, LCSW showed that patients with cancer and survivors of cancer who engaged in administrative payment tasks were more likely to experience treatment delays or treatment nonadherence.
09.27.2023
In an interview with the Philadelphia Inquirer, PC3I Associate Director Lola Fayanju commented on recently updated breast cancer screening recommendations.
02.14.2023
As part of the RadComp study, Penn Medicine and over 20 radiation centers nationwide are comparing the effectiveness of photon therapy and proton therapy to treat breast cancer.
01.12.2023
A team led by PC3I Innovation Faculty Ravi Parikh has found that machine learning-triggered behavioral nudges quadrupled the rates of seriousness illness conversations for patients with advance cancer.